Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Nov 21st 2019, Silver Chartbook: Sentiment silence and lies

Sentiment, silence and lies We spoke in our last silver chartbook about how to take a contrarian position. As well we explained how to bet against consensus. Sentiment is one aspect supporting a contrarian trader. This is obviously necessary to achieve a “buy low, sell ...
Korbinian Koller | November 22, 2019 |

Curis' Shares Take Off as FDA Clears IND Application for Monoclonal Anti-VISTA Antibody

Curis Inc. shares are up more than 130% and established a new 52-week high price after reporting that the FDA cleared the company's IND Application for CI-8993, its monoclonal anti-VISTA antibody. Biotechnology company Curis Inc. (CRIS:NASDAQ) , which concentrates...
Streetwise Reports | June 11, 2020 |

The promise of AI

In ‘The Terminator’ series of action films starring Arnold Schwarzenegger, a cybernetic organism (cyborg) is programmed from the future to go back in time and kill the mother of the scientist who leads the fight against Skynet, an artificial intelligence syst...
Richard (Rick) Mills | November 22, 2019 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

Cypress Development Corp. (TSX.V:CYP) Clayton Valley Lithium Project versus Chinese LCE/ EV ...

Cypress Development Corp. (TSX.V:CYP) Clayton Valley Lithium Project versus Chinese LCE/ EV battery supply The pause in industrial activity brought about by the covid-19 crisis has led us to a fork in the road with respect to the direction we as a society take in ...
Richard (Rick) Mills | May 19, 2020 |

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...
Richard (Rick) Mills | April 13, 2020 |

Cypress Development's Clayton Valley Lithium Project vs. Chinese LCE/EV Battery Supply

The pause in industrial activity brought about by the Covid-19 crisis has led us to a fork in the road with respect to the direction we as a society take in fulfilling the twin mandates of suppressing global warming and growing the economy in challenging times. To some ...
Streetwise Reports | May 22, 2020 |
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested